Dr Richard Mollard is the Chief Scientific Officer of PharmAust Ltd and the Chief Executive Officer of subsidiary company Pitney Pharmaceuticals Pty Ltd. Dr Mollard received a PhD in 1996 from Monash University and an MBA in 2006 from Melbourne Business School and the University of St Gallen, Switzerland.
Dr Mollard has over 25 years of national and international experience in biomedical technical diligence, business development and research design and translation. He has held drug R&D positions in France, the US and Australia working with: University Louis Pasteur/ IGBMC/ Bristol Myers Squibb, University of Michigan/ Eli Lilly & Co and Monash University. Dr Mollard also has in depth experience in biotech/pharma consultancies, start ups and capital raisings in jurisdictions including: Australia, Hong Kong and Mainland China, the UK, Canada, Singapore, Japan, India, Vietnam, Thailand and Malaysia.
Dr Mollard is the author of over 30 peer-reviewed and invited scientific journal publications and has assisted in raising over AUD 100 million in capital. He currently holds the position of Honorary Fellow with the Department of Veterinary Sciences and Agriculture at the University of Melbourne.
Dr Mollard is leading PharmAust’s drug manufacturing, formulation, development, discovery and clinical trial programs for human and canine cancer, neurodegenerative disease and COVID-19.